An evaluation of pathologic T3 lung cancer

A total of 35 pT3 patients of lung cancer underwent pulmonary resection from 1983 to 1997 in our department. The overall five-year survival rate of the 35 cases was 35.8%. There was no significant difference between the five-year survival rate of squamous cell carcinoma and that of adenocarcinoma. A...

Full description

Saved in:
Bibliographic Details
Published inKyobu geka. The Japanese journal of thoracic surgery Vol. 51; no. 11; p. 930
Main Authors Miyazawa, M, Yamanda, T, Aoki, T, Kaneko, K, Yoshida, K, Hanaoka, T, Machida, E, Takasuna, K, Kondo, R, Numanami, H, Haniuda, M, Amano, J
Format Journal Article
LanguageJapanese
Published Japan 01.10.1998
Subjects
Adenocarcinoma - mortality
Adenocarcinoma - pathology
Adenocarcinoma - surgery
Aged
Aged, 80 and over
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - surgery
Female
Humans
Lung Neoplasms - mortality
Lung Neoplasms - pathology
Lung Neoplasms - surgery
Lymph Node Excision
Male
Middle Aged
Neoplasm Invasiveness
Neoplasm Staging
Pneumonectomy
Survival Rate
Treatment Outcome
Online AccessGet more information

Cover

More Information
Summary:A total of 35 pT3 patients of lung cancer underwent pulmonary resection from 1983 to 1997 in our department. The overall five-year survival rate of the 35 cases was 35.8%. There was no significant difference between the five-year survival rate of squamous cell carcinoma and that of adenocarcinoma. A superior outcome was observed for cases of curative resection compared with that of non-curative resection. Five-year survival rates of 19 patients with N0 disease, 16 patients with N1 or N2 disease were 46.6% and 22.2% respectively (p < 0.05). There was no significant differences among the survival rates according to the site of tumor invasion. We concluded that the long-term survival of patients with pathologic T3 disease critically depended on the lymph node state and completeness of resection.
ISSN:0021-5252